Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug consisting of **hydrocodone**, **acetaminophen**, and **fentanyl**. All three components are used for pain management, particularly in cases of severe pain. - **Hydrocodone** is an opioid analgesic and antitussive agent that acts mainly as a mu-opioid receptor agonist in the central nervous system, leading to inhibition of ascending pain pathways, alteration of pain perception, and suppression of the cough reflex. - **Acetaminophen** (also known as paracetamol) is a non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, thereby reducing pain and fever. - **Fentanyl** is a highly potent synthetic opioid agonist, acting primarily on mu-opioid receptors. It provides rapid and strong analgesia suitable for breakthrough or persistent severe pain. This specific triple-drug combination is *not currently available as an approved pharmaceutical product* according to the search results. However, all three drugs are individually approved and frequently used in pain management, with hydrocodone/acetaminophen combinations being especially common for moderate-to-severe pain and fentanyl reserved for severe pain requiring strong opioids[1][2][3][5]. Combining all three is generally not standard clinical practice due to the risk of additive central nervous system and respiratory depression, as well as increased potential for abuse, overdose, and serious side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocodone + acetaminophen + fentanyl.